Switch theme
Sign up to access all valuation multiples
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
2003
312
LTM Revenue $95.5M
LTM EBITDA -$11.4M
$90.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MDxHealth has a last 12-month revenue of $95.5M and a last 12-month EBITDA of -$11.4M.
In the most recent fiscal year, MDxHealth achieved revenue of $90.0M and an EBITDA of -$22.0M.
MDxHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MDxHealth valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $70.2M | $90.0M | XXX | XXX | XXX |
| Gross Profit | $19.2M | $43.9M | XXX | XXX | XXX |
| Gross Margin | 27% | 49% | XXX | XXX | XXX |
| EBITDA | -$30.7M | -$22.0M | XXX | XXX | XXX |
| EBITDA Margin | -44% | -24% | XXX | XXX | XXX |
| Net Profit | -$44.0M | -$43.1M | XXX | XXX | XXX |
| Net Margin | -63% | -48% | XXX | XXX | XXX |
| Net Debt | $20.0M | $13.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MDxHealth's stock price is $2.
MDxHealth has current market cap of $77.2M, and EV of $90.5M.
See MDxHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $90.5M | $77.2M | XXX | XXX | XXX | XXX | $-0.94 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MDxHealth has market cap of $77.2M and EV of $90.5M.
MDxHealth's trades at 0.9x LTM EV/Revenue multiple, and -7.9x LTM EBITDA.
Analysts estimate MDxHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MDxHealth and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $90.5M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | -4.1x | XXX | XXX | XXX |
| P/E | -2.0x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -4.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMDxHealth's NTM/LTM revenue growth is 20%
MDxHealth's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, MDxHealth's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MDxHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MDxHealth and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 28% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -24% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -28% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -5% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 61% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 88% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MDxHealth acquired XXX companies to date.
Last acquisition by MDxHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . MDxHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MDxHealth founded? | MDxHealth was founded in 2003. |
| Where is MDxHealth headquartered? | MDxHealth is headquartered in United States of America. |
| How many employees does MDxHealth have? | As of today, MDxHealth has 312 employees. |
| Who is the CEO of MDxHealth? | MDxHealth's CEO is Mr. Michael K. McGarrity. |
| Is MDxHealth publicy listed? | Yes, MDxHealth is a public company listed on NAS. |
| What is the stock symbol of MDxHealth? | MDxHealth trades under MDXH ticker. |
| When did MDxHealth go public? | MDxHealth went public in 2008. |
| Who are competitors of MDxHealth? | Similar companies to MDxHealth include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of MDxHealth? | MDxHealth's current market cap is $77.2M |
| What is the current revenue of MDxHealth? | MDxHealth's last 12-month revenue is $95.5M. |
| What is the current EBITDA of MDxHealth? | MDxHealth's last 12-month EBITDA is -$11.4M. |
| What is the current EV/Revenue multiple of MDxHealth? | Current revenue multiple of MDxHealth is 0.9x. |
| What is the current EV/EBITDA multiple of MDxHealth? | Current EBITDA multiple of MDxHealth is -7.9x. |
| What is the current revenue growth of MDxHealth? | MDxHealth revenue growth between 2023 and 2024 was 28%. |
| Is MDxHealth profitable? | Yes, MDxHealth is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
